Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Homeland Security was posted on January 22, 2009. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Foot and Mouth Disease (FMD) and Rift Valley Fever (RVF) Vaccine Production

Closed
RSCB-09-00NNNFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Contractor's Facility - TBD, DC, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Homeland Security → Contract Administration Svcs Division
Contacts2 people available
OfficeWASHINGTON, DC, 20528, USA
Office AddressWASHINGTON, DC, 20528, USA
Contacts
Timothy L DavisContracting Officer

Full Description

Show more
The Department of Homeland Security, Science and Technology Directorate, intends to award one contract for FMD and RVF vaccine production using FAR Part 15 RFP procedures. A written solicitation will be issued. This will be a full and open competition, and DHS shall consider all proposals submitted by responsible sources. The anticipated award date is August, 2009. Description of Work: Pursuant to Homeland Security Presidential Directive-9 (HSPD-9), the Secretary of Homeland Security is responsible for coordinating the overall national effort to enhance the protection of the critical infrastructure and key resources of the United States. This includes the defense of agriculture and food. Under HSPD-9, DHS is tasked with accelerating and enhancing the development of countermeasures - including vaccines - for Foreign Animal Diseases (FADs). HSPD-9 also recognized the need for a federal stockpile and mandated the creation of the National Veterinary Stockpile. This effort is to support the development and production of Foot and Mouth Disease (FMD) and Rift Valley Fever (RVF) vaccines for the National Veterinary Stockpile. Specifically, the Contractor will be required to: (a) Produce master seeds (MS) for replication, deficient, human adenovirus serotype 5 vectored FMD (AdFMD) vaccines master seed cell lines (MSC) for FMD and RVF vaccines; (b) Produce pre-licensing serials (PLS) for AdFMD vaccines; (c) Develop AdFMD vaccine process improvement and yield optimization methods to decrease cost of goods of AdFMD vaccines; (d) Develop in vitro relative potency release assays for AdFMD vaccines; (e) Provide regulatory services, including management of clinical studies, to enable submission of a CVB product license applications for several AdFMD vaccine; and (f) Produce MS and master seed cell line (MSC) for rationally designed marker RVF vaccines. Only entities that have or are capable of obtaining a U.S. Veterinary Biologics Establishment License (see (CFR 102.3(a)) will be eligible for the award of this contract. Performance under this contract will occur at the Contractor's place of business. Deliveries, including the master seeds, cell lines, and proof of regulatory compliance, are to be shipped to a TBD DHS address. It is anticipated that this will be a 4 year effort, with a 1 year base period and 3 one year option periods.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS